Ji Jian/Jin Qiao/Zhou Dongfang ACS Nano: A nano-assembly of supramolecular prodrug for liver cancer chemotherapy enhanced by reactive nitrogen species
The development of controllable reactive nitrogen species (RNS) generation systems for cancer treatment still faces challenges. Here, Ji Jian, Jinqiao of Zhejiang University, and Zhou Dongfang of Southern Medical University jointly reported a supramolecular prodrug nano-assembly (SPNA) strategy that co-delivers nitric oxide (NO) donors and can induce the production of superoxide anions (O2). •–) chemotherapeutic drugs are used for liver cancer chemotherapy enhanced by reactive nitrogen. The molar ratio of platinum (IV) prodrug and NO donor can be precisely controlled by SPNA Pt/NO. Platinum (II) and NO will be released in cells, producing highly toxic RNS, peroxynitrite anion (ONOO-). ONOO- can down-regulate the levels of glutathione reductase (GR) and DNA damage repair protein XPA, thereby synergistically reducing tumor repair of DNA damage caused by platinum drugs. The efficacy of SPNA Pt/NO was verified on subcutaneous xenograft liver cancer models and orthotopic cisplatin-resistant liver cancer models. This strategy of combined administration of NO donors and O2•-induction chemotherapeutics provides an insightful direction for RNS-mediated tumor therapy.
Yongyan Deng, Tailoring Supramolecular Prodrug Nanoassemblies for Reactive Nitrogen Species-Potentiated Chemotherapy of Liver Cancer, ACS Nano, 2021.
DOI: 10.1021/acsnano.1c00698
https://doi.org/10.1021/acsnano.1c00698
This information is sourced from the Internet for academic exchanges. If there is any infringement, please contact us to delete it immediately
18915694570
Previous： Adv. Funct. Mater: Het
